Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.
Vir Biotechnology Inc
-- (-)
NaN
0.00
0.00
-
-
-
-
Vir Biotechnology Inc
Vir Biotechnology is a US healthcare company focusing on clinical-stage immunology. Founded in 2016 with headquarters in San Francisco, it’s dedicated to creating a world without infectious disease using its cutting-edge technologies. The company’s process is to first identify limitations of a patient’s immune system for combatting a particular pathogen, and when it has detected the vulnerabilities of the pathogen, it can then apply technologies using its antibody platform that will lead to effective treatment. Diseases that Vir has treated include Hepatitis B, Covid-19, influenza and HIV/AIDS. Vir Biotechnology stock is listed on the Nasdaq exchange. Start spread betting or trading CFDs on our Vir Biotechnology share price.
Why 2 million+ traders and investors globally choose us¹
12,000 financial instruments- Tight spreads and no hidden fees
- Robust platform stability ²
- Ultra-fast execution ³
- 24/5 customer support
NaN
NaN
| 1 | NaN - NaN | 0% |
| Mon | Invalid Date - Invalid Date |
| Tue | Invalid Date - Invalid Date |
| Wed | Invalid Date - Invalid Date |
| Thu | Invalid Date - Invalid Date |
| Fri | Invalid Date - Invalid Date |
¹
²
³
²
³
Loading...
Loading...